SNAP 5089

Discontinued Product

SNAP 5089 (Cat. No. 2398) has been withdrawn from sale for commercial reasons.
Description: Subtype-selective α1A antagonist
Chemical Name: 5-[[[3-(4,4-Diphenyl-1-piperidinyl)propyl]amino]carbonyl]-1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)-3-pyridinecarboxylic acid methyl ester hydrochloride
Purity: ≥98% (HPLC)
Literature (1)

Biological Activity for SNAP 5089

SNAP 5089 is a subtype-selective α1A-adrenoceptor antagonist that displays > 600-fold selectivity over other adrenoceptors (Kivalues are 0.35, 220, 370, 540, 800 and 1200 nM for α1A, α1B, α2C, α1D, α2B and α2A subtypes respectively and 540 nM for L-type Ca2+ channels). Inhibits noradrenalin-induced contractions in rabbit vascular and lower urinary tissues.

Technical Data for SNAP 5089

M. Wt 645.19
Formula C36H40N4O5.HCl
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 157066-77-8
PubChem ID 56972175
Smiles CC1=C(C(OC)=O)C(C2=CC=C([N+]([O-])=O)C=C2)C(C(NCCCN3CCC(C4=CC=CC=C4)(C5=CC=CC=C5)CC3)=O)=C(C)N1.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for SNAP 5089

References are publications that support the biological activity of the product.

Wetzel et al (1995) Discovery of α1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine. J.Med.Chem. 38 1579 PMID: 7752182

Leonardi et al (1997) Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15-2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, Part I. J.Pharmacol.Exp.Ther. 281 1272 PMID: 9190863

Kava et al (1998) α1L-adrenceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br.J.Pharmacol. 123 1359 PMID: 9579731

View Related Products by Target

View Related Products by Product Action

View all Adrenergic α1 Receptor Antagonists

Keywords: SNAP 5089, SNAP 5089 supplier, Subtype, selective, α1A-adrenoceptor, alpha1A-adrenoceptors, a1a-adrenoceptors, α1a-adrenergic, alpha1a-adrenergic, a1a-adrenergic, antagonists, Receptors, SNAP5089, Adrenergic, Alpha-1, 2398, Tocris Bioscience

Citations for SNAP 5089

Citations are publications that use Tocris products.

Currently there are no citations for SNAP 5089.

Reviews for SNAP 5089

There are currently no reviews for this product. Be the first to review SNAP 5089 and earn rewards!

Have you used SNAP 5089?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.